

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 4.80790261 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 4.72994507 |
| 3 | regulation of sequestering of triglyceride (GO:0010889) | 4.49570349 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.24102884 |
| 5 | positive regulation of fatty acid oxidation (GO:0046321) | 3.85059571 |
| 6 | sarcomere organization (GO:0045214) | 3.78945949 |
| 7 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74272187 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.69991487 |
| 9 | cardiac myofibril assembly (GO:0055003) | 3.69491743 |
| 10 | response to inactivity (GO:0014854) | 3.65869438 |
| 11 | regulation of fatty acid oxidation (GO:0046320) | 3.64814526 |
| 12 | carnitine transmembrane transport (GO:1902603) | 3.60398990 |
| 13 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.59592368 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.59163212 |
| 15 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.53142376 |
| 16 | tricarboxylic acid cycle (GO:0006099) | 3.51217887 |
| 17 | succinate metabolic process (GO:0006105) | 3.49027895 |
| 18 | myofibril assembly (GO:0030239) | 3.47169731 |
| 19 | interkinetic nuclear migration (GO:0022027) | 3.42216477 |
| 20 | regulation of skeletal muscle contraction (GO:0014819) | 3.41176195 |
| 21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.39626466 |
| 22 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39417499 |
| 23 | tachykinin receptor signaling pathway (GO:0007217) | 3.37883295 |
| 24 | biotin metabolic process (GO:0006768) | 3.37343284 |
| 25 | fatty acid beta-oxidation (GO:0006635) | 3.34669981 |
| 26 | behavioral response to nicotine (GO:0035095) | 3.34442334 |
| 27 | carnitine transport (GO:0015879) | 3.31971635 |
| 28 | amino-acid betaine transport (GO:0015838) | 3.31971635 |
| 29 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.30625508 |
| 30 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.30427318 |
| 31 | NADH metabolic process (GO:0006734) | 3.29968339 |
| 32 | muscle filament sliding (GO:0030049) | 3.24925656 |
| 33 | actin-myosin filament sliding (GO:0033275) | 3.24925656 |
| 34 | acetyl-CoA metabolic process (GO:0006084) | 3.24793936 |
| 35 | regulation of cell communication by electrical coupling (GO:0010649) | 3.22294704 |
| 36 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.19188856 |
| 37 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.17608255 |
| 38 | oxaloacetate metabolic process (GO:0006107) | 3.16137193 |
| 39 | regulation of relaxation of muscle (GO:1901077) | 3.12345339 |
| 40 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.09944148 |
| 41 | cardiac muscle contraction (GO:0060048) | 3.09200203 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 3.09184504 |
| 43 | regulation of cofactor metabolic process (GO:0051193) | 3.09184504 |
| 44 | plasma membrane repair (GO:0001778) | 3.08415008 |
| 45 | fatty acid catabolic process (GO:0009062) | 3.00696458 |
| 46 | triglyceride catabolic process (GO:0019433) | 2.99431275 |
| 47 | cellular response to epinephrine stimulus (GO:0071872) | 2.98853086 |
| 48 | fatty acid oxidation (GO:0019395) | 2.98763737 |
| 49 | skeletal muscle contraction (GO:0003009) | 2.97302961 |
| 50 | myotube cell development (GO:0014904) | 2.97053189 |
| 51 | regulation of actin filament-based movement (GO:1903115) | 2.95599471 |
| 52 | low-density lipoprotein particle clearance (GO:0034383) | 2.95293710 |
| 53 | cardiac muscle hypertrophy (GO:0003300) | 2.95211447 |
| 54 | fatty acid homeostasis (GO:0055089) | 2.95177376 |
| 55 | acylglycerol catabolic process (GO:0046464) | 2.94677655 |
| 56 | neutral lipid catabolic process (GO:0046461) | 2.94677655 |
| 57 | response to epinephrine (GO:0071871) | 2.93450704 |
| 58 | lipid oxidation (GO:0034440) | 2.92674925 |
| 59 | striated muscle hypertrophy (GO:0014897) | 2.92653634 |
| 60 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91615678 |
| 61 | adrenergic receptor signaling pathway (GO:0071875) | 2.89988908 |
| 62 | lysine metabolic process (GO:0006553) | 2.89057711 |
| 63 | lysine catabolic process (GO:0006554) | 2.89057711 |
| 64 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.88624478 |
| 65 | vocalization behavior (GO:0071625) | 2.88299248 |
| 66 | muscle contraction (GO:0006936) | 2.86390970 |
| 67 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.82828165 |
| 68 | brown fat cell differentiation (GO:0050873) | 2.82561087 |
| 69 | actin filament-based movement (GO:0030048) | 2.82397207 |
| 70 | striated muscle contraction (GO:0006941) | 2.74700818 |
| 71 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.74210224 |
| 72 | muscle hypertrophy (GO:0014896) | 2.74173583 |
| 73 | exogenous drug catabolic process (GO:0042738) | 2.73834869 |
| 74 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.73575606 |
| 75 | skeletal muscle adaptation (GO:0043501) | 2.73315988 |
| 76 | aspartate family amino acid catabolic process (GO:0009068) | 2.73285835 |
| 77 | detection of calcium ion (GO:0005513) | 2.72615880 |
| 78 | cell communication involved in cardiac conduction (GO:0086065) | 2.72396353 |
| 79 | actin-mediated cell contraction (GO:0070252) | 2.71811814 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 2.71599544 |
| 81 | complement activation, alternative pathway (GO:0006957) | 2.71497347 |
| 82 | adult heart development (GO:0007512) | 2.70662798 |
| 83 | urinary tract smooth muscle contraction (GO:0014848) | 2.70587847 |
| 84 | glycogen catabolic process (GO:0005980) | 2.70465336 |
| 85 | drug catabolic process (GO:0042737) | 2.70285132 |
| 86 | valine metabolic process (GO:0006573) | 2.70127373 |
| 87 | alpha-linolenic acid metabolic process (GO:0036109) | 2.69323839 |
| 88 | positive regulation of cation channel activity (GO:2001259) | 2.68294462 |
| 89 | muscle system process (GO:0003012) | 2.67967051 |
| 90 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.66949317 |
| 91 | phospholipid homeostasis (GO:0055091) | 2.66326997 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 2.64940138 |
| 93 | positive regulation of glycogen metabolic process (GO:0070875) | 2.64875695 |
| 94 | regulation of striated muscle contraction (GO:0006942) | 2.63058062 |
| 95 | creatine metabolic process (GO:0006600) | 2.61534628 |
| 96 | somite development (GO:0061053) | 2.60956004 |
| 97 | regulation of sulfur metabolic process (GO:0042762) | 2.60867875 |
| 98 | cell communication by electrical coupling (GO:0010644) | 2.60768130 |
| 99 | membrane depolarization during action potential (GO:0086010) | 2.60167187 |
| 100 | thioester biosynthetic process (GO:0035384) | 2.59373845 |
| 101 | acyl-CoA biosynthetic process (GO:0071616) | 2.59373845 |
| 102 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.58807474 |
| 103 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.58807474 |
| 104 | neuromuscular synaptic transmission (GO:0007274) | 2.57766053 |
| 105 | neurotransmitter catabolic process (GO:0042135) | 2.57661022 |
| 106 | actomyosin structure organization (GO:0031032) | 2.57422837 |
| 107 | glucan catabolic process (GO:0009251) | 2.57410007 |
| 108 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.57280397 |
| 109 | monocarboxylic acid catabolic process (GO:0072329) | 2.56690986 |
| 110 | branched-chain amino acid catabolic process (GO:0009083) | 2.56337300 |
| 111 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.56144068 |
| 112 | muscle fiber development (GO:0048747) | 2.54667252 |
| 113 | short-chain fatty acid metabolic process (GO:0046459) | 2.54508967 |
| 114 | skeletal muscle fiber development (GO:0048741) | 2.54384287 |
| 115 | dicarboxylic acid catabolic process (GO:0043649) | 2.53135766 |
| 116 | lipid particle organization (GO:0034389) | 2.53020729 |
| 117 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.52717800 |
| 118 | quaternary ammonium group transport (GO:0015697) | 2.52539512 |
| 119 | regulation of membrane repolarization (GO:0060306) | 2.52489305 |
| 120 | positive regulation of digestive system process (GO:0060456) | 2.51034578 |
| 121 | intracellular lipid transport (GO:0032365) | 2.50174936 |
| 122 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.47647038 |
| 123 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.46096360 |
| 124 | neuronal action potential propagation (GO:0019227) | 2.45652510 |
| 125 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.45650900 |
| 126 | regulation of p38MAPK cascade (GO:1900744) | 2.43407342 |
| 127 | branched-chain amino acid metabolic process (GO:0009081) | 2.42203751 |
| 128 | positive regulation of myoblast differentiation (GO:0045663) | 2.42079456 |
| 129 | definitive hemopoiesis (GO:0060216) | 2.40503447 |
| 130 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.38149393 |
| 131 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.36974038 |
| 132 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.34596728 |
| 133 | regulation of female receptivity (GO:0045924) | 2.33817638 |
| 134 | growth hormone receptor signaling pathway (GO:0060396) | 2.33263230 |
| 135 | arginine catabolic process (GO:0006527) | 2.32158025 |
| 136 | negative regulation of protein localization to cell surface (GO:2000009) | 2.32006346 |
| 137 | response to cold (GO:0009409) | 2.31358848 |
| 138 | relaxation of muscle (GO:0090075) | 2.30819380 |
| 139 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.30557202 |
| 140 | striated muscle adaptation (GO:0014888) | 2.29718190 |
| 141 | regulation of action potential (GO:0098900) | 2.27737476 |
| 142 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.27368148 |
| 143 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.27368148 |
| 144 | regulation of endothelial cell differentiation (GO:0045601) | 2.26528312 |
| 145 | adenosine metabolic process (GO:0046085) | 2.26492086 |
| 146 | relaxation of cardiac muscle (GO:0055119) | 2.23883387 |
| 147 | nucleus localization (GO:0051647) | 2.23251691 |
| 148 | cellular response to growth hormone stimulus (GO:0071378) | 2.22796117 |
| 149 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.22734727 |
| 150 | cGMP-mediated signaling (GO:0019934) | 2.18490453 |
| 151 | regulation of germinal center formation (GO:0002634) | 2.17749877 |
| 152 | glyoxylate metabolic process (GO:0046487) | 2.16505593 |
| 153 | oxidative demethylation (GO:0070989) | 2.16105953 |
| 154 | cAMP catabolic process (GO:0006198) | 2.15670277 |
| 155 | regulation of sarcomere organization (GO:0060297) | 2.13079099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.52193407 |
| 2 | * EZH2_22144423_ChIP-Seq_EOC_Human | 3.40938989 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.89438729 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75969953 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.74456511 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.25264500 |
| 7 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.20744748 |
| 8 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.18041488 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14012425 |
| 10 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.13371644 |
| 11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.09995180 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07054694 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05547750 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.00631335 |
| 15 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00048299 |
| 16 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.92095464 |
| 17 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.92095464 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.91536029 |
| 19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87314838 |
| 20 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.82973053 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81952907 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.79975669 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77869513 |
| 24 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.77501949 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 1.72570695 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70272696 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.67449878 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67392423 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.67224001 |
| 30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65046786 |
| 31 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64250013 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63599307 |
| 33 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.58184117 |
| 34 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.55963709 |
| 35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.54308164 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52797145 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.48484990 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.47173335 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45059011 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43793243 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43769383 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41377576 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40147840 |
| 44 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39038272 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38975526 |
| 46 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38968783 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38955801 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37039416 |
| 49 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36918967 |
| 50 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36736254 |
| 51 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36736254 |
| 52 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.32393644 |
| 53 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30984981 |
| 54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30786535 |
| 55 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29399608 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.29016547 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27715214 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27122647 |
| 59 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25447426 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24595123 |
| 61 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23548265 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23452343 |
| 63 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22347861 |
| 64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.22206156 |
| 65 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22190202 |
| 66 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21461541 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20721413 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17651024 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.16819213 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14810706 |
| 71 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14333894 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12210759 |
| 73 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10925215 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.10877083 |
| 75 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.10444457 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10028077 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09641975 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09343383 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09050926 |
| 80 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08802360 |
| 81 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07092269 |
| 82 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05225187 |
| 83 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04240863 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04195544 |
| 85 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04195544 |
| 86 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03723652 |
| 87 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.02683814 |
| 88 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02134321 |
| 89 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.01725704 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00338012 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99352409 |
| 92 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99304515 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99080841 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98720400 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98720400 |
| 96 | * AR_19668381_ChIP-Seq_PC3_Human | 0.98163228 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97702049 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96847039 |
| 99 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96542153 |
| 100 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96321103 |
| 101 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95307751 |
| 102 | P300_19829295_ChIP-Seq_ESCs_Human | 0.95082234 |
| 103 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94877756 |
| 104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94627756 |
| 105 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.94425568 |
| 106 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94409181 |
| 107 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93949941 |
| 108 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93949941 |
| 109 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93228163 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.93159079 |
| 111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92954491 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92548809 |
| 113 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.92217492 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90342316 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89805234 |
| 116 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.89805086 |
| 117 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89331103 |
| 118 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.89310321 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88977659 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88927006 |
| 121 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88857390 |
| 122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88288013 |
| 123 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87225880 |
| 124 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.86570560 |
| 125 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86351177 |
| 126 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86315788 |
| 127 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.85598870 |
| 128 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85592650 |
| 129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85397524 |
| 130 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.84947674 |
| 131 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84629006 |
| 132 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84383732 |
| 133 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.84337391 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84216789 |
| 135 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.83806463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.00321902 |
| 2 | MP0005670_abnormal_white_adipose | 4.17397563 |
| 3 | MP0000751_myopathy | 4.04592879 |
| 4 | MP0003646_muscle_fatigue | 3.97332326 |
| 5 | MP0004130_abnormal_muscle_cell | 3.51369560 |
| 6 | MP0004215_abnormal_myocardial_fiber | 3.09713971 |
| 7 | MP0005666_abnormal_adipose_tissue | 2.90351372 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.76220977 |
| 9 | MP0004036_abnormal_muscle_relaxation | 2.62165129 |
| 10 | MP0000749_muscle_degeneration | 2.53632286 |
| 11 | MP0005330_cardiomyopathy | 2.52740440 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.27946962 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.10761246 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.08946778 |
| 15 | MP0004087_abnormal_muscle_fiber | 2.08780615 |
| 16 | MP0002653_abnormal_ependyma_morphology | 2.07262971 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.05840259 |
| 18 | MP0005167_abnormal_blood-brain_barrier | 2.04273867 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.03834463 |
| 20 | MP0005375_adipose_tissue_phenotype | 2.00987151 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.98348342 |
| 22 | MP0004484_altered_response_of | 1.96640024 |
| 23 | MP0002638_abnormal_pupillary_reflex | 1.94716159 |
| 24 | MP0003011_delayed_dark_adaptation | 1.93913303 |
| 25 | MP0002972_abnormal_cardiac_muscle | 1.89097152 |
| 26 | MP0006138_congestive_heart_failure | 1.84950987 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.81115731 |
| 28 | MP0002139_abnormal_hepatobiliary_system | 1.77360514 |
| 29 | MP0003137_abnormal_impulse_conducting | 1.77213019 |
| 30 | MP0005365_abnormal_bile_salt | 1.72466242 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.71239451 |
| 32 | MP0002971_abnormal_brown_adipose | 1.68574567 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.62813953 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.62660848 |
| 35 | MP0000750_abnormal_muscle_regeneration | 1.62246397 |
| 36 | MP0001984_abnormal_olfaction | 1.61427214 |
| 37 | MP0002269_muscular_atrophy | 1.59674817 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.57916514 |
| 39 | MP0000747_muscle_weakness | 1.57908899 |
| 40 | MP0005385_cardiovascular_system_phenoty | 1.57565345 |
| 41 | MP0001544_abnormal_cardiovascular_syste | 1.57565345 |
| 42 | MP0005360_urolithiasis | 1.56077611 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.53846256 |
| 44 | MP0005085_abnormal_gallbladder_physiolo | 1.52297782 |
| 45 | MP0004085_abnormal_heartbeat | 1.51868415 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.51200005 |
| 47 | MP0000759_abnormal_skeletal_muscle | 1.50759925 |
| 48 | MP0002822_catalepsy | 1.46705874 |
| 49 | MP0005369_muscle_phenotype | 1.38256348 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.36884636 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.36353466 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.35583360 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.35043968 |
| 54 | MP0003724_increased_susceptibility_to | 1.34066202 |
| 55 | MP0010630_abnormal_cardiac_muscle | 1.32619856 |
| 56 | MP0003828_pulmonary_edema | 1.32101792 |
| 57 | MP0005275_abnormal_skin_tensile | 1.30647259 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.28579346 |
| 59 | MP0001968_abnormal_touch/_nociception | 1.26033891 |
| 60 | MP0003635_abnormal_synaptic_transmissio | 1.25213614 |
| 61 | MP0005535_abnormal_body_temperature | 1.24070592 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.22510815 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.22224293 |
| 64 | MP0005334_abnormal_fat_pad | 1.22146259 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.20158683 |
| 66 | MP0008995_early_reproductive_senescence | 1.16840710 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.16339430 |
| 68 | MP0009745_abnormal_behavioral_response | 1.16326348 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.16177108 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.12014616 |
| 71 | MP0006036_abnormal_mitochondrial_physio | 1.09436456 |
| 72 | MP0003329_amyloid_beta_deposits | 1.08934967 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.06637217 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.06637217 |
| 75 | MP0002108_abnormal_muscle_morphology | 1.04561592 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.04251166 |
| 77 | MP0004510_myositis | 1.02972096 |
| 78 | MP0003252_abnormal_bile_duct | 1.02913883 |
| 79 | MP0009115_abnormal_fat_cell | 1.02752677 |
| 80 | MP0002933_joint_inflammation | 1.02396299 |
| 81 | MP0004233_abnormal_muscle_weight | 0.99615463 |
| 82 | MP0004270_analgesia | 0.99417973 |
| 83 | MP0002064_seizures | 0.98799923 |
| 84 | MP0009046_muscle_twitch | 0.98396216 |
| 85 | MP0002063_abnormal_learning/memory/cond | 0.97941929 |
| 86 | MP0010368_abnormal_lymphatic_system | 0.96773992 |
| 87 | MP0005253_abnormal_eye_physiology | 0.96423059 |
| 88 | MP0005448_abnormal_energy_balance | 0.95965552 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.95930721 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.94535558 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.91692677 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.89726626 |
| 93 | MP0005503_abnormal_tendon_morphology | 0.89513845 |
| 94 | MP0003690_abnormal_glial_cell | 0.89373666 |
| 95 | MP0002736_abnormal_nociception_after | 0.89188013 |
| 96 | MP0000230_abnormal_systemic_arterial | 0.88445736 |
| 97 | MP0003880_abnormal_central_pattern | 0.86979063 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.86978715 |
| 99 | MP0005332_abnormal_amino_acid | 0.86772962 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86730824 |
| 101 | MP0002272_abnormal_nervous_system | 0.86503650 |
| 102 | MP0004043_abnormal_pH_regulation | 0.84836120 |
| 103 | MP0000383_abnormal_hair_follicle | 0.83962683 |
| 104 | MP0002735_abnormal_chemical_nociception | 0.83797991 |
| 105 | MP0002127_abnormal_cardiovascular_syste | 0.83757647 |
| 106 | MP0003045_fibrosis | 0.82502316 |
| 107 | MP0001661_extended_life_span | 0.81075413 |
| 108 | MP0005266_abnormal_metabolism | 0.78644832 |
| 109 | MP0005165_increased_susceptibility_to | 0.78263543 |
| 110 | MP0005647_abnormal_sex_gland | 0.77998146 |
| 111 | MP0000343_altered_response_to | 0.77133646 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.77126405 |
| 113 | MP0004924_abnormal_behavior | 0.77126405 |
| 114 | MP0001486_abnormal_startle_reflex | 0.76418633 |
| 115 | MP0001970_abnormal_pain_threshold | 0.75277447 |
| 116 | MP0000733_abnormal_muscle_development | 0.75169639 |
| 117 | MP0002234_abnormal_pharynx_morphology | 0.75152815 |
| 118 | MP0003705_abnormal_hypodermis_morpholog | 0.74163779 |
| 119 | MP0009278_abnormal_bone_marrow | 0.74132285 |
| 120 | MP0004147_increased_porphyrin_level | 0.73059998 |
| 121 | MP0003879_abnormal_hair_cell | 0.72508398 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.71970448 |
| 123 | MP0005452_abnormal_adipose_tissue | 0.71672205 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71587895 |
| 125 | MP0002572_abnormal_emotion/affect_behav | 0.71021737 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.71006860 |
| 127 | MP0002067_abnormal_sensory_capabilities | 0.70622462 |
| 128 | MP0002557_abnormal_social/conspecific_i | 0.70319782 |
| 129 | MP0004142_abnormal_muscle_tone | 0.69626164 |
| 130 | MP0008874_decreased_physiological_sensi | 0.69567703 |
| 131 | MP0004272_abnormal_basement_membrane | 0.69086992 |
| 132 | MP0003195_calcinosis | 0.68658012 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.68031831 |
| 134 | MP0003633_abnormal_nervous_system | 0.67172179 |
| 135 | MP0002970_abnormal_white_adipose | 0.67052974 |
| 136 | MP0000609_abnormal_liver_physiology | 0.65573363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.39412718 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.29149099 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 4.86361571 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.82721451 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.68940821 |
| 6 | Hyporeflexia of lower limbs (HP:0002600) | 4.48992511 |
| 7 | Myoglobinuria (HP:0002913) | 4.14813364 |
| 8 | Ventricular tachycardia (HP:0004756) | 4.06112155 |
| 9 | Increased connective tissue (HP:0009025) | 3.96920229 |
| 10 | Difficulty running (HP:0009046) | 3.94247390 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 3.87988313 |
| 12 | Atrial fibrillation (HP:0005110) | 3.81876782 |
| 13 | Right ventricular cardiomyopathy (HP:0011663) | 3.79788542 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.75726619 |
| 15 | Lipoatrophy (HP:0100578) | 3.54815566 |
| 16 | Primary atrial arrhythmia (HP:0001692) | 3.53600267 |
| 17 | Focal motor seizures (HP:0011153) | 3.48191242 |
| 18 | Oligomenorrhea (HP:0000876) | 3.41328027 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 3.40774836 |
| 20 | Distal arthrogryposis (HP:0005684) | 3.30702855 |
| 21 | Supraventricular tachycardia (HP:0004755) | 3.29974142 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 3.29288260 |
| 23 | Supraventricular arrhythmia (HP:0005115) | 3.27626830 |
| 24 | Syncope (HP:0001279) | 3.26300048 |
| 25 | Bundle branch block (HP:0011710) | 3.16256682 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.12157206 |
| 27 | Hyperventilation (HP:0002883) | 3.09693529 |
| 28 | Type 1 muscle fiber predominance (HP:0003803) | 3.00640551 |
| 29 | Myopathic facies (HP:0002058) | 2.93621616 |
| 30 | Myotonia (HP:0002486) | 2.91615611 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 2.89990998 |
| 32 | Ketosis (HP:0001946) | 2.86729727 |
| 33 | Dilated cardiomyopathy (HP:0001644) | 2.83144210 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 2.82271279 |
| 35 | Hyperglycinuria (HP:0003108) | 2.80283406 |
| 36 | Ketoacidosis (HP:0001993) | 2.77078598 |
| 37 | Prolonged QT interval (HP:0001657) | 2.75562849 |
| 38 | Areflexia of lower limbs (HP:0002522) | 2.72817325 |
| 39 | Complement deficiency (HP:0004431) | 2.71491890 |
| 40 | Aortic aneurysm (HP:0004942) | 2.69833638 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.68084624 |
| 42 | Ventricular arrhythmia (HP:0004308) | 2.64153158 |
| 43 | Stomach cancer (HP:0012126) | 2.61625774 |
| 44 | Ventricular fibrillation (HP:0001663) | 2.59834801 |
| 45 | Heart block (HP:0012722) | 2.59381872 |
| 46 | Palpitations (HP:0001962) | 2.57804990 |
| 47 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.54624760 |
| 48 | Subaortic stenosis (HP:0001682) | 2.54624760 |
| 49 | Asymmetric septal hypertrophy (HP:0001670) | 2.54211985 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.49776916 |
| 51 | Frequent falls (HP:0002359) | 2.49130416 |
| 52 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.44660145 |
| 53 | Atrioventricular block (HP:0001678) | 2.44453159 |
| 54 | Abnormal atrioventricular conduction (HP:0005150) | 2.43718766 |
| 55 | Muscle stiffness (HP:0003552) | 2.42624686 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40373196 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.40373196 |
| 58 | Muscle fiber inclusion bodies (HP:0100299) | 2.39606826 |
| 59 | Dysmetric saccades (HP:0000641) | 2.37959268 |
| 60 | Hypoglycemic coma (HP:0001325) | 2.36795512 |
| 61 | Epidermoid cyst (HP:0200040) | 2.36150596 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.35952756 |
| 63 | Hyperammonemia (HP:0001987) | 2.35168814 |
| 64 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.34525724 |
| 65 | Hyperkalemia (HP:0002153) | 2.32215700 |
| 66 | Acanthosis nigricans (HP:0000956) | 2.28702270 |
| 67 | Gaze-evoked nystagmus (HP:0000640) | 2.28515757 |
| 68 | Broad metatarsal (HP:0001783) | 2.28285029 |
| 69 | Cerebral palsy (HP:0100021) | 2.27908060 |
| 70 | Generalized muscle weakness (HP:0003324) | 2.27288279 |
| 71 | Deep venous thrombosis (HP:0002625) | 2.24732973 |
| 72 | Facial diplegia (HP:0001349) | 2.23556188 |
| 73 | Hyperlipoproteinemia (HP:0010980) | 2.23157910 |
| 74 | Abnormal EKG (HP:0003115) | 2.20713659 |
| 75 | Broad-based gait (HP:0002136) | 2.20580024 |
| 76 | Difficulty climbing stairs (HP:0003551) | 2.19450711 |
| 77 | Testicular atrophy (HP:0000029) | 2.17709150 |
| 78 | Myokymia (HP:0002411) | 2.15248508 |
| 79 | Abnormality of the ischium (HP:0003174) | 2.13687779 |
| 80 | Xanthomatosis (HP:0000991) | 2.12219793 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10505459 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.10505459 |
| 83 | Round ear (HP:0100830) | 2.09930014 |
| 84 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09327982 |
| 85 | Neck muscle weakness (HP:0000467) | 2.09214138 |
| 86 | Clumsiness (HP:0002312) | 2.07020835 |
| 87 | Prolonged bleeding time (HP:0003010) | 2.06700791 |
| 88 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.04231266 |
| 89 | Cerebral edema (HP:0002181) | 2.02091501 |
| 90 | Spontaneous abortion (HP:0005268) | 2.01606746 |
| 91 | Focal seizures (HP:0007359) | 2.00133079 |
| 92 | Neoplasm of the heart (HP:0100544) | 1.99033387 |
| 93 | Progressive cerebellar ataxia (HP:0002073) | 1.98953301 |
| 94 | Hypoplastic ischia (HP:0003175) | 1.96756989 |
| 95 | Skin nodule (HP:0200036) | 1.96746999 |
| 96 | Renal cortical cysts (HP:0000803) | 1.95933422 |
| 97 | Muscular dystrophy (HP:0003560) | 1.95054435 |
| 98 | Increased muscle lipid content (HP:0009058) | 1.94716869 |
| 99 | Proximal amyotrophy (HP:0007126) | 1.92449500 |
| 100 | Pancreatic fibrosis (HP:0100732) | 1.92279616 |
| 101 | Pulmonary artery stenosis (HP:0004415) | 1.91874224 |
| 102 | Toxemia of pregnancy (HP:0100603) | 1.91797414 |
| 103 | Absent phalangeal crease (HP:0006109) | 1.91469464 |
| 104 | Hip contracture (HP:0003273) | 1.91066116 |
| 105 | Limited hip movement (HP:0008800) | 1.90641605 |
| 106 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.89792841 |
| 107 | Cholelithiasis (HP:0001081) | 1.89218310 |
| 108 | Atonic seizures (HP:0010819) | 1.88526976 |
| 109 | Pancreatic cysts (HP:0001737) | 1.88521997 |
| 110 | Hypolipoproteinemia (HP:0010981) | 1.87677854 |
| 111 | Distal lower limb amyotrophy (HP:0008944) | 1.87651614 |
| 112 | Pheochromocytoma (HP:0002666) | 1.83807069 |
| 113 | Abnormal social behavior (HP:0012433) | 1.82924934 |
| 114 | Impaired social interactions (HP:0000735) | 1.82924934 |
| 115 | Type II lissencephaly (HP:0007260) | 1.82750105 |
| 116 | Hypertriglyceridemia (HP:0002155) | 1.82485219 |
| 117 | Distal lower limb muscle weakness (HP:0009053) | 1.81425389 |
| 118 | Anterior segment dysgenesis (HP:0007700) | 1.81373760 |
| 119 | Nemaline bodies (HP:0003798) | 1.81063749 |
| 120 | Decreased circulating renin level (HP:0003351) | 1.81049426 |
| 121 | Genetic anticipation (HP:0003743) | 1.79386831 |
| 122 | Congenital stationary night blindness (HP:0007642) | 1.79114060 |
| 123 | Febrile seizures (HP:0002373) | 1.78574422 |
| 124 | Tachypnea (HP:0002789) | 1.78127192 |
| 125 | Cerebellar dysplasia (HP:0007033) | 1.78032733 |
| 126 | Metabolic acidosis (HP:0001942) | 1.77926743 |
| 127 | Bulbar palsy (HP:0001283) | 1.75856660 |
| 128 | Waddling gait (HP:0002515) | 1.75845659 |
| 129 | Hyperglycinemia (HP:0002154) | 1.75171183 |
| 130 | Generalized tonic-clonic seizures (HP:0002069) | 1.73815411 |
| 131 | Left ventricular hypertrophy (HP:0001712) | 1.73715355 |
| 132 | Rimmed vacuoles (HP:0003805) | 1.73589019 |
| 133 | Weak cry (HP:0001612) | 1.73338697 |
| 134 | Nephronophthisis (HP:0000090) | 1.72808668 |
| 135 | Bile duct proliferation (HP:0001408) | 1.72755136 |
| 136 | Abnormal biliary tract physiology (HP:0012439) | 1.72755136 |
| 137 | Scapular winging (HP:0003691) | 1.72076578 |
| 138 | Abnormality of the renal cortex (HP:0011035) | 1.71969642 |
| 139 | Malignant hyperthermia (HP:0002047) | 1.71783738 |
| 140 | Hyperglycemia (HP:0003074) | 1.71313447 |
| 141 | EMG: neuropathic changes (HP:0003445) | 1.70242834 |
| 142 | Abnormality of complement system (HP:0005339) | 1.69509050 |
| 143 | Abnormal gallbladder morphology (HP:0012437) | 1.69386688 |
| 144 | Type 2 muscle fiber atrophy (HP:0003554) | 1.67581050 |
| 145 | True hermaphroditism (HP:0010459) | 1.64926120 |
| 146 | Steppage gait (HP:0003376) | 1.63248269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 3.40477481 |
| 2 | TTN | 3.32865737 |
| 3 | MAP4K2 | 3.29340825 |
| 4 | OBSCN | 3.10285438 |
| 5 | PHKG2 | 3.02457145 |
| 6 | PHKG1 | 3.02457145 |
| 7 | PDK3 | 2.62605266 |
| 8 | PDK4 | 2.62605266 |
| 9 | BCKDK | 2.49716789 |
| 10 | CAMK1G | 2.27340210 |
| 11 | CAMK1D | 2.22959425 |
| 12 | CASK | 2.22573329 |
| 13 | MYLK | 2.20460710 |
| 14 | EPHA3 | 2.11945186 |
| 15 | NTRK3 | 2.05351156 |
| 16 | SIK1 | 1.99896433 |
| 17 | DMPK | 1.93446733 |
| 18 | MAP2K4 | 1.85678216 |
| 19 | PIK3CA | 1.84694810 |
| 20 | MUSK | 1.83102585 |
| 21 | MAPKAPK3 | 1.80269115 |
| 22 | PINK1 | 1.78918874 |
| 23 | TIE1 | 1.74906663 |
| 24 | MAP3K4 | 1.74129234 |
| 25 | DAPK2 | 1.73874494 |
| 26 | PDK2 | 1.73321784 |
| 27 | INSRR | 1.73268515 |
| 28 | TRIB3 | 1.69770076 |
| 29 | MARK1 | 1.66930633 |
| 30 | EPHA4 | 1.65280875 |
| 31 | ICK | 1.41393715 |
| 32 | MAPK13 | 1.36802590 |
| 33 | MAP3K7 | 1.30314562 |
| 34 | RIPK1 | 1.25854869 |
| 35 | STK39 | 1.20402089 |
| 36 | MAP2K7 | 1.19564595 |
| 37 | MAP3K6 | 1.19250594 |
| 38 | ADRBK2 | 1.15982901 |
| 39 | PRKAA2 | 1.14526194 |
| 40 | MAP2K2 | 1.09514820 |
| 41 | LATS1 | 1.08304375 |
| 42 | FER | 1.07425106 |
| 43 | AKT3 | 1.00908452 |
| 44 | PKN1 | 0.98720736 |
| 45 | PTK2B | 0.97863879 |
| 46 | FES | 0.96838229 |
| 47 | MAPK12 | 0.94973875 |
| 48 | SGK3 | 0.92591171 |
| 49 | KDR | 0.92556533 |
| 50 | MAP3K12 | 0.92460477 |
| 51 | GRK1 | 0.92239166 |
| 52 | ZAK | 0.91967451 |
| 53 | MAPK7 | 0.91319224 |
| 54 | PRKD3 | 0.90222997 |
| 55 | CAMK1 | 0.88441171 |
| 56 | CAMK2D | 0.88147015 |
| 57 | FGFR2 | 0.87064911 |
| 58 | OXSR1 | 0.86373671 |
| 59 | TRPM7 | 0.86350943 |
| 60 | CAMK2A | 0.85260904 |
| 61 | EEF2K | 0.84369393 |
| 62 | SGK2 | 0.83717816 |
| 63 | ERBB4 | 0.81778754 |
| 64 | PRKCH | 0.81467907 |
| 65 | PRKAA1 | 0.80615909 |
| 66 | MAPK4 | 0.78544297 |
| 67 | NME1 | 0.77633795 |
| 68 | PRKD1 | 0.76438021 |
| 69 | ROCK1 | 0.74858480 |
| 70 | WNK4 | 0.73868271 |
| 71 | SGK494 | 0.70954237 |
| 72 | SGK223 | 0.70954237 |
| 73 | PRKCE | 0.70376797 |
| 74 | NLK | 0.70323721 |
| 75 | PAK3 | 0.68605743 |
| 76 | BMPR1B | 0.68590652 |
| 77 | GRK7 | 0.67479779 |
| 78 | PDGFRA | 0.66370322 |
| 79 | PDPK1 | 0.66139723 |
| 80 | KIT | 0.64968426 |
| 81 | PRPF4B | 0.63992681 |
| 82 | ADRBK1 | 0.63878280 |
| 83 | MST1R | 0.63482875 |
| 84 | NUAK1 | 0.62505635 |
| 85 | SGK1 | 0.61486555 |
| 86 | CAMK4 | 0.61175271 |
| 87 | DAPK1 | 0.59878769 |
| 88 | STK38 | 0.59558743 |
| 89 | CAMK2B | 0.59525132 |
| 90 | MAPK15 | 0.59215818 |
| 91 | TGFBR2 | 0.58782336 |
| 92 | CAMK2G | 0.58449215 |
| 93 | PDK1 | 0.57779356 |
| 94 | CDK5 | 0.57187935 |
| 95 | RPS6KA6 | 0.54666557 |
| 96 | PRKACG | 0.54233339 |
| 97 | ERN1 | 0.53998895 |
| 98 | MAP3K1 | 0.53126396 |
| 99 | GRK5 | 0.52992260 |
| 100 | SYK | 0.52403501 |
| 101 | EPHB1 | 0.52312023 |
| 102 | RPS6KA2 | 0.52121666 |
| 103 | EPHB2 | 0.52113081 |
| 104 | PRKG1 | 0.52111741 |
| 105 | IKBKB | 0.52081077 |
| 106 | GRK6 | 0.51218630 |
| 107 | JAK1 | 0.50396803 |
| 108 | PRKACB | 0.50359675 |
| 109 | STK11 | 0.49743993 |
| 110 | NTRK2 | 0.49385484 |
| 111 | TXK | 0.48075411 |
| 112 | ROCK2 | 0.47398490 |
| 113 | PKN2 | 0.47291463 |
| 114 | RET | 0.45379760 |
| 115 | PRKACA | 0.44661049 |
| 116 | MARK2 | 0.44496035 |
| 117 | PAK6 | 0.44155747 |
| 118 | DAPK3 | 0.44116593 |
| 119 | RPS6KC1 | 0.44107914 |
| 120 | RPS6KL1 | 0.44107914 |
| 121 | MAP2K1 | 0.43833185 |
| 122 | MAPK3 | 0.43489193 |
| 123 | FGFR4 | 0.43357344 |
| 124 | STK38L | 0.42823958 |
| 125 | WNK3 | 0.42752195 |
| 126 | RPS6KA3 | 0.42135385 |
| 127 | FGFR3 | 0.42104772 |
| 128 | CHUK | 0.41779925 |
| 129 | IKBKE | 0.40481033 |
| 130 | CDC42BPA | 0.40418061 |
| 131 | WNK1 | 0.40344457 |
| 132 | MAP2K6 | 0.40341712 |
| 133 | DYRK1A | 0.40059496 |
| 134 | MAP3K11 | 0.39840352 |
| 135 | JAK2 | 0.39478466 |
| 136 | MAP3K5 | 0.38329649 |
| 137 | PIK3CG | 0.38329030 |
| 138 | TAOK3 | 0.37582145 |
| 139 | FRK | 0.37008407 |
| 140 | TNK2 | 0.35932938 |
| 141 | RPS6KA5 | 0.35016024 |
| 142 | TEC | 0.34851446 |
| 143 | PRKCQ | 0.34011346 |
| 144 | BTK | 0.33372948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.13256825 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.05567508 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71237792 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69680386 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48889578 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.39789790 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31635077 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.30335782 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30166748 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.16103392 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.12532543 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.98376739 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.88211210 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86287848 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.85487007 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.72577538 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.67705051 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.66353137 |
| 19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64939458 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64831955 |
| 21 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.64181085 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62004642 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.56052788 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47918891 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40145868 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33750843 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32433996 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30732584 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.30722306 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.26025232 |
| 31 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.25400880 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.24839236 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.22235616 |
| 34 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.21198622 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19522238 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.18997346 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.18746074 |
| 38 | Phototransduction_Homo sapiens_hsa04744 | 1.17722921 |
| 39 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.16722204 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14601720 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.11624909 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11284477 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11166611 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.10306068 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.07093512 |
| 46 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.06109161 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.06088089 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.03756885 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.03436217 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01646167 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.00192486 |
| 52 | Insulin resistance_Homo sapiens_hsa04931 | 0.97976910 |
| 53 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.96155826 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.95122477 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 0.93708064 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.92589479 |
| 57 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92106254 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91058299 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 0.86328113 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.86238543 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.85871127 |
| 62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.85789550 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85608226 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84399695 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.83036920 |
| 66 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82063944 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.81333212 |
| 68 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80341486 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78946998 |
| 70 | Taste transduction_Homo sapiens_hsa04742 | 0.78068500 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77004715 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76794761 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.76782869 |
| 74 | ABC transporters_Homo sapiens_hsa02010 | 0.76539208 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76179321 |
| 76 | Insulin secretion_Homo sapiens_hsa04911 | 0.75236470 |
| 77 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74920665 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.73866479 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70910554 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.70271680 |
| 81 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.70157078 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69886059 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68938269 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68788211 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.68028426 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.67965843 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67529274 |
| 88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67198551 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63619970 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58965431 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58607331 |
| 92 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58200944 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56890857 |
| 94 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55639685 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55028877 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54150039 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.52858231 |
| 98 | Olfactory transduction_Homo sapiens_hsa04740 | 0.51825748 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51443727 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50839543 |
| 101 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.49681000 |
| 102 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49634153 |
| 103 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48615359 |
| 104 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47860526 |
| 105 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46708177 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46097104 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.45785705 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.44699540 |
| 109 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43603553 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43524750 |
| 111 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.41312147 |
| 112 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.41029631 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40704754 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40154778 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38943796 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35510150 |
| 117 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34790317 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.34241149 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33465634 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.32495312 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31861463 |
| 122 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.31647204 |
| 123 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.31421083 |
| 124 | Gap junction_Homo sapiens_hsa04540 | 0.31186805 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31169380 |

